Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.1541
+0.0781 (102.76%)
May 14, 2025, 10:39 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Vaccine Discovery and Development
58.47K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Switzerland
58.47K